1. Zoledronic acid and clinical fractures and mortality after hip fracture
- Author
-
Lyles, Kenneth W., Colon-Emeric, Cathleen S., Magaziner, Jay S., Adachi, Jonathan D., Pieper, Carl F., Mautalen, Carlos, Hyldstrup, Lars, Recknor, Chris, Nordsletten, Lars, Moore, Kathy A., Lavecchia, Catherine, Jie Zhang, Mesenbrink, Peter, Hodgson, Patricia K., Abrams, Ken, Orloff, John J., Horowitz, Zebulun, Eriksen, Erik Fink, and Boonen, Steven
- Subjects
Zoledronic acid -- Patient outcomes ,Zoledronic acid -- Research ,Hip joint -- Fractures ,Hip joint -- Drug therapy ,Hip joint -- Care and treatment ,Hip joint -- Prevention - Abstract
The effectiveness of zoledronic acid in prevention of new clinical fractures, to patients undergone hip fracture surgery is studied. Results concluded yearly infusion of zoledronic acid within 90 days of hip fracture surgery reduced risk of new clinical fractures raising survival rate.
- Published
- 2007